ICA Group Wealth Management’s AbbVie ABBV Stock Holding History

ICA Group Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$532K	Sell	3,104 -6,426	-67%	-$1.06M	0.32%	49
2024 Q1	$1.74M	Sell	9,530 -249	-3%	-$42.9K	0.35%	59
2023 Q4	$1.52M	Sell	9,779 -388	-4%	-$56.6K	0.34%	61
2023 Q3	$1.52M	Sell	10,167 -400	-4%	-$58.7K	0.43%	56
2023 Q2	$1.42M	Sell	10,567 -565	-5%	-$82.9K	0.36%	64
2023 Q1	$1.77M	Buy	11,132 +91	+0.8%	+$13.9K	0.42%	51
2022 Q4	$1.78M	Sell	11,041 -6,563	-37%	-$1.01M	0.42%	54
2022 Q3	$2.36M	Buy	17,604 +281	+2%	+$40.3K	0.5%	46
2022 Q2	$2.46M	Sell	17,323 -310	-2%	-$47.4K	0.46%	51
2022 Q1	$2.58M	Buy	+17,633	New	+$2.56M	0.49%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ICA Group Wealth Management's ABBV Position: Q2 2024 in Review

ICA Group Wealth Management reduced its AbbVie (ABBV) stake by 67% in Q2 2024, selling an estimated $1.06M and leaving 3,104 shares worth $532K. The position accounts for 0.32% of the portfolio, ranked #49.

ICA Group Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 10 quarters since. The position peaked at $2.58M in Q1 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

ICA Group Wealth Management held 3,104 shares of AbbVie worth $532K as of Q2 2024.
ICA Group Wealth Management sold 6,426 AbbVie shares in Q2 2024, an estimated $1.06M.
AbbVie made up 0.32% of ICA Group Wealth Management's portfolio in Q2 2024, its #49 holding.
ICA Group Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 10 quarters since.
ICA Group Wealth Management's AbbVie position peaked at $2.58M in Q1 2022.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.